相似化合物
379227-03-9 1849-55-4 1038399-45-9欧盟法规
C&L通报上下游产品
CAS号75-16-1 甲基溴化镁 | CAS号932-35-4 2-氰基-3-羟基吡啶 | CAS号874-24-8 3-羟基-2-吡啶甲酸 | CAS号676-58-4 甲基氯化镁 | CAS号917-64-6 甲基碘化镁 | CAS号63668-59-7 2-cyanopyridin-... | CAS号917-54-4 甲基锂 | CAS号81376-88-7 Ethanone, 1-(3-... | CAS号73406-50-5 3-羟基吡啶甲酸乙酯 | CAS号107096-06-0 ethyl 3-(methox... | CAS号107096-11-7 Furo[3,2-b]pyri... | CAS号1051383-43-7 1-B°C-4'-oxo-sp... | CAS号107096-09-3 3-甲基-呋喃并[3,2-b]... | CAS号86467-39-2 2-甲基噁唑并[4,5-B]吡啶 | CAS号83988-39-0 3-methyl-[1,2]o... | CAS号55502-23-3 4-hydroxypyrano...📜尼可刹胺杂质1置于硼酸三异丙酯,Lithium Diisopropyl Amide体系中,用 四氢呋喃,水 用作溶剂,化学反应 1.83H,反应生成1-(3-羟基吡啶-2-基)乙酮
参考文献:甲硅烷基醚的锂化:邻位油炸羟基酮的形成
标题:甲硅烷基醚的锂化:邻位油炸羟基酮的形成
摘要:使用lda(二异丙基锂酰胺)和氯硅烷的简单试剂组合,开发了使用cipe辅助的α-甲硅烷基碳负离子对n,N-二乙基芳基酰胺进行羟基定向的烷基化反应(cipe =络合物诱导的邻近效应).报道了对该机理的研究,以及该方法在阴离子snieckus-Fries重排中的应用,以高效合成强效磷脂酰肌醇3-激酶(pi3K)抑制剂ly294002.
Doi:10.1002/anie.201404495
海关参考信息
- 2912110000-甲醛
2912120000-乙醛
2933310010-吡啶
2905199090-其他饱和一元醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:CN-103880740-B
优先权日:2014-04-14
标题 :Synthesis of 4-nitro-3-hydroxy-2-pyridinecarboxylic acid
专利号:CN-103880740-A
优先权日:2014-04-14
标 题:Synthesis of 4-nitro-3-hydroxy-2-pyridinecarboxylic acid
专利号:US-9957277-B2
优先权日:2015-11-25
标题 :eIF4A-inhibiting compounds and methods related thereto
发明人:ERNST JUSTIN T; REICH SIEGFRIED H; SPRENGELER PAUL A; TRAN CHINH VIET; PACKARD Garrick Kenneth; XIANG ALAN X; NILEWSKI CHRISTIAN; MICHELS THEO
权利人:EFFECTOR THERAPEUTICS INC
摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. n nFor Formula I compounds X, Y, R 1 , R 2 , R 3a , R 3b , R 4a , R 4b and R 5 are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4A and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.